Shark Tank CureSee
In this episode of Shark Tank India CureSee, AI-based vision therapy website CureSee presents the pitch. Will the founder get a deal from the sharks? To know about the deal read till the end.
| Company name | CureSee |
| Founders | Puneet, Amit Sahni and Jatin Kaushik |
| Ask | ₹ 40 lakhs for 5% equity |
CureSee Founder
Puneet is an optometrist, Amit Sahni is also an optometrist and Jatin Kaushik is an electrical and electronics engineer.
Puneet and Jatin are childhood friends. They met with Amit from an industrial connection. They started their company in the year 2017 and utilizing the covid time they have made the world’s no. 1 eye check-up software brand to date.
About the company CureSee
30 crore people suffer from a lazy eye or Amblyopia which is not getting correct vision even after wearing spectacles. The treatment when we visit to check our eyes is wearing an eye patch. So in order to solve the issue of wearing uncomfortable eye patches, CureSee was found. CureSee is the world’s first artificial intelligence-based vision therapy website which focuses on 3 problems of the human eye:
- Amblyopia.
- Squint eye.
- Convergence Insufficiency.
- One can avail the service by the following steps:
- Free eye screening on their own website.
- Suggest vision therapy exercises.
- Positive results in 1-2 months of usage.
The company is awarded and supported by the government of India. They have catered to 2500+ patients.
They have published 1 research paper already and 2 research papers are submitted for approval from AIIMS. They have used anaglyph glasses for playing several games and from there the results are drawn. They have 310 active customers.
Ask by the Owner CureSee
The owner asked 40 lakhs rupees for 5% equity in the company.
CureSee Sales And Revenue
Revenue is generated through the hospital as a SaaS company. The subscription is around 12000 to 18000 rupees for 3 months. Last month the sales were 2.64 lakhs rupees.
Offers and counter offers
Namita offers 40 lakhs rupees for 10% equity in the company.
Peyush offers 2 deals:
- 1 crore rupees for 25% equity.
Or - 40 lakhs for 10% equity.
Namita counters offer 40 lakhs for 7.5% equity with increased valuation.
Pitcher counters offer40 lakhs for 7.5% equity to Peyush as they want him to close the deal with them.
Namita again counters for 40 lakhs in exchange of 5% equity.
Peyush’s counters offer 50 lakhs for 10% equity.
CureSee Final deal
The deal was finalized with Peyush for 50 lakhs rupees in exchange for 10% equity in the company.